DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,231,494 | -63.6% | 137,751 | -54.2% | 0.42% | -59.7% |
| Q2 2023 | $3,383,449 | -32.2% | 300,751 | -30.7% | 1.03% | -26.0% |
| Q1 2023 | $4,988,137 | -32.7% | 433,751 | -32.3% | 1.39% | -39.2% |
| Q4 2022 | $7,417,157 | +67.1% | 641,068 | +83.1% | 2.29% | +61.0% |
| Q3 2022 | $4,439,000 | -99.2% | 350,068 | +8957.4% | 1.42% | -75.7% |
| Q2 2022 | $562,568,000 | +48481.0% | 3,865 | -99.2% | 5.87% | +2148.3% |
| Q1 2022 | $1,158,000 | -79.5% | 476,000 | 0.0% | 0.26% | -79.2% |
| Q4 2021 | $5,641,000 | +38.9% | 476,000 | +90.4% | 1.26% | +28.4% |
| Q3 2021 | $4,060,000 | +43.0% | 250,000 | +85.2% | 0.98% | +30.5% |
| Q2 2021 | $2,840,000 | +95.5% | 135,000 | +43.8% | 0.75% | +95.3% |
| Q1 2021 | $1,453,000 | – | 93,886 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |